Mohammad Ali Sahraian

Dr Mohammad Ali Sahraian is a neurologist and a researcher currently working in Sina Hospital which is affiliated to Tehran University of Medical Sciences. His main field of research is multiple sclerosis, and he established the first specialised ward for that disease in Iran. He is one of the two main authors of "MRI Atlas of MS Lesions", published by Springer. Provided by Wikipedia
Showing 1 - 8 results of 8 for search 'Mohammad Ali Sahraian', query time: 0.01s Refine Results
  1. 1
    Charles Bonnet Syndrome (CBS) in a Patient With Secondary Progressive Multiple Sclerosis: A Case Report

    Charles Bonnet Syndrome (CBS) in a Patient With Secondary Progressive Multiple Sclerosis: A Case Report by Shima Jahani, Atefeh Eidi Ardizi, MohammadAli Sahraian

    Published 2025-07-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    The interplay between endoplasmic reticulum stress and inflammation in multiple sclerosis

    The interplay between endoplasmic reticulum stress and inflammation in multiple sclerosis by Zhila Maghbooli, Forough Azam Sayahpour, Tarlan Varzandi, Mahya Rouhollahi Masoumi, Mohammad Ali Sahraian

    Published 2025-07-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Effect of Fampridine on cognition in patients with multiple sclerosis (MS): a systematic review and meta-analysis

    Effect of Fampridine on cognition in patients with multiple sclerosis (MS): a systematic review and meta-analysis by Abdorreza naser moghadasi, Narges Ebrahimi, Sara Bagherieh, Aida Mohammadi, Mohammad ali Sahraian, Mahsa Ghajarzadeh

    Published 2025-06-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Evaluation of Multiple Sclerosis from the Perspective of Conventional Medicine and Traditional Persian Medicine, Considering the Concept of Hemorheology

    Evaluation of Multiple Sclerosis from the Perspective of Conventional Medicine and Traditional Persian Medicine, Considering the Concept of Hemorheology by Mahdi Yaseliani, Hossein Rezaeizadeh, Abdolreaza Naser Moghadasi, Mohammad Ali Sahraian, Mehrdad Karimi, Mahdi Alizadeh Vaghasloo

    Published 2025-06-01
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Investigating the Correlation Between Cognitive Function and Fasting Blood Sugar, Fasting Insulin Level and Insulin Sensitivity in Patients With Multiple Sclerosis

    Investigating the Correlation Between Cognitive Function and Fasting Blood Sugar, Fasting Insulin Level and Insulin Sensitivity in Patients With Multiple Sclerosis by Nasim Rezaeimanesh, Naghme Abbasi Kasbi, Roghayyeh Saeedi, Mohammad Ali Sahraian, Soodeh Razeghi Jahromi, Abdorreza Naser Moghadasi

    Published 2024-11-01
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    Long-term effects of air pollution on the incidence and progression of multiple sclerosis: A population cohort study in Isfahan, Iran.

    Long-term effects of air pollution on the incidence and progression of multiple sclerosis: A population cohort study in Isfahan, Iran. by Omid Mirmosayyeb, Saeed Vaheb, Alireza Afshari-Safavi, Aysa Shaygannejad, Mohammad Ali Sahraian, Ali Atamaleki, Sharareh Eskandarieh, Vahid Shaygannejad

    Published 2025-01-01
    Get full text
    Article
    Save to List
    Saved in:
  7. 7
    Cell therapy with placenta-derived mesenchymal stem cells for secondary progressive multiple sclerosis patients in a phase 1 clinical trial

    Cell therapy with placenta-derived mesenchymal stem cells for secondary progressive multiple sclerosis patients in a phase 1 clinical trial by Ameneh Shokati, Mohsen Nikbakht, Mohammad Ali Sahraian, Roghayyeh Saeedi, Elnaz Asadollahzadeh, Nasim Rezaeimanesh, Bahram Chahardouli, Zeinab Gharaylou, Seyed Asadollah Mousavi, Jafar Ai, Abdorreza Naser Moghadasi

    Published 2025-05-01
    Get full text
    Article
    Save to List
    Saved in:
  8. 8
    Evaluating efficacy and safety of ocrelizumab biosimilar (Xacrel) compared to the originator (Ocrevus) in relapsing multiple sclerosis: a phase III, randomized, equivalency, clinical trial

    Evaluating efficacy and safety of ocrelizumab biosimilar (Xacrel) compared to the originator (Ocrevus) in relapsing multiple sclerosis: a phase III, randomized, equivalency, clinic... by Mohammad Ali Sahraian, Roya Abolfazli, Vahid Shaygannejad, Fereshteh Ashtari, Nastaran Majdinasab, Samira Navardi, Seyed Mohammad Baghbanian, Behnaz Sedighi, Abdorreza Naser Moghadasi, Mohammad Ali Nahayati, Hamidreza Ghalyanchi Langroodi, Seyed Ehsan Mohammadianinejad, Nahid Beladi Moghadam, Hormoz Ayromlou, Alireza Nikseresht, Masoud Ghiasian, Nazanin Razazian, Elnaz Asadollahzadeh, Araz Sabzvari, Hamidreza Kafi, Sogol Albooyeh

    Published 2024-10-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: